Fierce Competition in CDHIC Guangzhou Finals: Top Three Medical Innovation Teams Advance with Groundbreaking Solutions

At 5:30 p.m. on July 28, the Guangzhou Division Finals of the “ALL IN – China Health and Medical Big Data Industry Innovation Competition” officially concluded at the Guangzhou Development District Science and Technology Financial Service Center. As the second regional final of the competition, the Guangzhou division, a key competitive region, saw 30 medical innovation projects shortlisted for intense rivalry.

Guangzhou Competition Venue

It is reported that Beijing Rhino Hanhai Technology Co., Ltd., Samoa Shang Jienisi Investment Holding Co., Ltd. Taiwan Branch, and Liuzhou Kangyun Internet Technology Co., Ltd. secured first, second, and third place, respectively, in the Angel Star category of this regional final; Guangzhou Kangliming Biotechnology Co., Ltd., Lianyi Medical Technology (Beijing) Co., Ltd., and Guangdong Akang Health Technology Group Co., Ltd. claimed first, second, and third place, respectively, in the Growth Star category of this regional final, further demonstrating the growing strength of enterprises in the medical technology sector.

Angel Star First Place: Beijing Xiniu Hanhai Technology Co., Ltd.

Award Presenter: Zhou Mi (Managing Partner, Puhua Capital; far right)

Runner-up of the Angel Star Award: Janes Investment Holdings Co., Ltd. Samoa, Taiwan Branch

Presenter: Niu Hongliang (Vice President of Huawei's Smart Wearables and Sports Health Division, far right）

Third Place, Angel Star: Liuzhou Kangyun Internet Technology Co., Ltd.

Award Presenter: Liu Zongyu (Executive Dean of VCBeat, far right)

1st Place in the Rising Star Award: Guangzhou Kangliming Biotechnology Co., Ltd.

Award Presenter: Wang Xiaocen (Partner, CEC Health Fund, far right)

Runner-up for the Rising Star Award: Lianyi Medical Technology (Beijing) Co., Ltd.

Award Presenter: Lu Jing (Senior Vice President of Penguin Doctor, far right）

Third Place in Rising Stars: Guangdong Akang Health Technology Group Co., Ltd.

Award Presenter: Zhang Qian (General Manager of Guan Hao Life and Health Technology Park Co., Ltd., far right）

Young Enterprises Account for Over Half, Demonstrating Stronger Innovation Power

Shortlisted for this Regional FinalOf the 30 medical innovation projects, 14 were from companies established before 2016, and 16 were from companies established in or after 2016. Among the latter, six companies were founded in 2016, six in 2017, and four in 2018. These companies are more deeply rooted in the fields of tech-driven healthcare, healthcare informatics, and broader health industries, demonstrating strong innovative capabilities.

Wang Xiaocen, Partner at CEC Health Fund, stated that many of the roadshow projects in this competition involved“Cloud + AI”: The overall average quality of projects is relatively high.

Closing Remarks by Wang Xiaocen, Partner at CEC Health Fund

Healthcare IT and tech-driven medical projects account for the largest share, featuring intense competition and strong capital attraction.

The shortlisted projects for this regional final cover healthcare informatization, medical technology, general health, medical devices, consumer healthcare, primary care, biotechnology, pharmaceuticals, andThe TMT big data covers a total of nine major sectors. Among them, the healthcare informatics sector has seven projects, and the tech-healthcare sector has nine projects, accounting for 51.61% of the total shortlisted projects, indicating intense competition. Of these 16 projects, one has secured Series C funding, four have secured Series B funding, one has secured Series A funding, and three have secured Pre-A funding, demonstrating strong capital-raising capabilities and gaining favor from more professional investors.

Rooted in the field of medical technology, two champions lead the way in cancer screening and big data cloud platforms

Rising Star Award - First Place—Guangzhou Kangliming Biotechnology Co., Ltd. is a high-tech enterprise founded by outstanding scientists who studied in the United States. Backed by well-known venture capital funds, the company specializes in the research and development, production, and sales of tumor screening and diagnostic products, including “Chang’an Xin,” a non-invasive fecal screening kit for colorectal cancer. The company is headquartered in the Guangzhou Development District’s Technology Enterprise Accelerator. Possessing independent intellectual property rights and world-class R&D capabilities, the company has filed numerous invention and utility model patents and will continue to expand its intellectual property portfolio. The technical development of “Chang’an Xin,” the fecal screening kit for colorectal cancer, has been completed. The company is currently expanding its team and continuously strengthening its capabilities across all areas. Guided by the noble ideal of “Your Health, Our Mission,” we strive to achieve breakthroughs and progress in tumor screening, diagnosis, treatment evaluation, and prognosis monitoring, ultimately benefiting the public.

First Place in the Angel Star Awards—Beijing Rhino Hanhai Technology Co., Ltd. is a provider of big data technical services for healthcare, focusing on the application and implementation of big data technologies (including machine learning, deep learning, interpretable learning, data mining, data visualization, etc.) in the healthcare sector. As a leading player in China’s healthcare big data industry, Rhino Tech boasts world-class AI experts, internationally advanced big data algorithms and data mining capabilities, and a domestically leading big data cloud platform. With the mission to “unlock the infinite value of healthcare big data,” the company builds a bridge between traditional healthcare data and the future transformation of the medical industry.

Second Place, Rising Star Award——Lianyi Medical Technology (Beijing) Co., Ltd. is a B2B e-commerce platform for medical devices, connecting Chinese medical device manufacturers with global end retailers. By significantly enhancing supply chain efficiency, we provide merchants and healthcare providers with the most cost-effective products. Leveraging an innovative cross-border e-commerce export model, we target the global medical device market, valued at RMB 2 trillion, utilizing high-efficiency online marketing to serve over 200,000 small and medium-sized medical device retailers through our online procurement services. The founding team of Lianyi Medical comprises veterans with extensive experience in global procurement and sales within the medical device industry, as well as technical leaders from the cross-border divisions of renowned e-commerce platforms. We have established our headquarters in Beijing, with logistics service centers in Shanghai and Shenzhen, and maintain partnerships with two leading integrated service providers specializing in cross-border export logistics, trade, and settlement. On the supply side, we collaborate with China’s leading medical device manufacturers. Our initial product lineup includes operating room consumables, infusion products, urology supplies, respiratory and anesthesia equipment, feeding supplies, and rehabilitation consumables. In terms of market expansion, we leverage our existing base of nearly 10,000 clients and employ multi-channel online and offline promotional strategies. Additionally, we engage in cross-industry collaborations with resource partners that possess established customer bases, such as a well-known third-party testing institution in the United States.

Runner-up, Angel Star— Samoa Business Jennis Investment Holdings Co., Ltd., Taiwan Branch is a technology R&D company specializing in smart wearable devices and internet-related businesses. It currently holds global authorization for its independently developed patent on respiratory flow testing technology. The underlying principle involves converting airflow during inhalation and exhalation into ultrasonic waves via a specially designed ultrasonic metal whistle at the mouthpiece end, and calculating pulmonary function during breathing cycles using specialized algorithms. As the world’s first company to integrate respiratory data with weather conditions and PM2.5 levels, it connects users’ health information with cloud-based big data through smartphones. Acting like a personal respiratory health assistant, it cares for lung health and encourages individuals to address their breathing issues with a simple yet scientific approach.In the clinical phase, as the number of patients using the device increases, integrating these respiratory data with patients’ medication dosages and therapeutic outcomes, while correlating them with environmental air pollution parameters, will create substantial medical value. Taking inhaled powdered medications for asthma and respiratory diseases as an example, the per-inhalation dosage suitable for Western populations may not be appropriate for Eastern populations. However, once these inhaled medications are loaded into pneumatic inhalers, the single-use dosage is fixed. Given that environmental air pollution parameters vary significantly—for instance, between Beijing and Taiwan—determining the most accurate and effective single medication dose absolutely relies on continuous big data analysis of respiratory systems.

Third Place: Rising Star Award——Guangdong Akang Health Technology Group Co., Ltd. is a comprehensive group company specializing in the operation of prescription drugs for chronic diseases, chronic disease management, hospital prescription circulation, e-commerce operations, and the growth of out-of-hospital prescriptions. The group wholly owns three subsidiaries: Guangzhou Zhenkang Pharmaceutical Co., Ltd., Guangdong Akang Pharmacy Chain Co., Ltd., and Guangdong Yunyao Technology Co., Ltd. The group’s business portfolio covers innovative services such as clinical promotion of new and specialty drugs, B2C, B2B, self-operated DTP (Direct-to-Patient) pharmacies, DTP pharmacy alliances, Cloud Drug Warehouse, and Cloud Prescription.The group currently employs over 350 staff members, with an average age of 26; more than 70% have professional backgrounds in medicine or pharmacy. The company currently manages over 12,000 SKUs of prescription drugs for chronic diseases and has established direct cooperative relationships with more than 800 domestic and international pharmaceutical manufacturers. It holds exclusive out-of-hospital agency rights for over 800 products, with a product portfolio covering treatments for more than 1,000 types of chronic, critical, and rare diseases. Currently, the Cloud Drug Warehouse DTP project collaborates with over 600 small and medium-sized pharmacy chains, as well as more than 50,000 independent pharmacies, clinics, and village health stations. It provides empowering services such as customer-ordering assistance, prescription fulfillment, O2O (Online-to-Offline) services, and chronic disease management to reduce prescription leakage and improve medication adherence among chronic disease patients. The Cloud Prescription platform has registered over 30,000 grassroots physicians, providing customer-ordering assistance services to nearly 100,000 pharmacies, clinics, and grassroots doctors daily, enabling more people at the grassroots level to access high-quality medications.Over the next five years, leveraging the opportunities presented by the separation of prescribing and dispensing and the outward flow of prescriptions, we will focus on integrated supply chain services for medications treating chronic, critical, and rare diseases. Our goal is to provide superior services to end-user chronic disease patients and become the leader in the out-of-hospital operation of the prescription drug market.

Third Place, Angel Star——Liuzhou Kangyun Interconnected Technology Co., Ltd. was established in March 2016, focusing on the research and development and application of mobile point-of-care health testing technologies. By using medical testing as an entry point, it covers all aspects of healthcare, including patient guidance, diagnosis, treatment, rehabilitation, and health management. The company is dedicated to disease screening, mobile healthcare, and comprehensive health services, providing original, foundational, critical, and optimized IoT+ solutions. Relying on its independently developed intelligent biological reagents and cloud-based intelligent detection systems as core technologies, and integrating cutting-edge technologies such as the Internet of Things (IoT), cloud computing, big data, and artificial intelligence, the company performs routine health tests—including vital signs, urinalysis, biochemistry, immunology, nucleic acid analysis, and specific protein analysis—as well as food safety, environmental monitoring, and pet testing. This “Mobile Internet +” in vitro diagnostics (IVD) approach creates a lightweight, “instrument-free” testing method that enables rapid acquisition of test results via mobile devices.

Puhua CapitalManagementZhou Mi, Partner and Co-Chair of the Jury for the Guangzhou Division Finals, stated that he is optimistic about the shortlisted projects in this division and hopes to see all winning entries from this region compete again at the Grand Finals.

Closing Remarks by Zhou Mi, Managing Partner of Puhua Capital and Co-Chair of the Jury for the Guangzhou Division Finals

According to VCBeat, the China Health and Medical Big Data Industry Innovation Competition will continue until September, with the remaining Hangzhou (Following the regional finals in Chengdu (August 11), Wuhan (August 18), and Beijing (Traditional Chinese Medicine + TMT Special Session, August 25), all outstanding projects shortlisted for the grand finals will compete in the final round at the Beijing Hotel on September 8, 2018.

Group Photo of the Judges in the Guangzhou Division

In response to the requirements of participating projects and to provide more innovative initiatives across China with opportunities for exposure, the registration channel for the competition will remain open. We look forward to welcoming creative and driven individuals to join the China Health and Medical Big Data Industry Innovation Competition.“Outpacing time with thought, gaining insight into the future of big data,” has become the emerging force we have long awaited!

Official Website:http://vcbeat.top/cdhic

Scan the QR Code to Register for the Competition